255 related articles for article (PubMed ID: 10227815)
21. In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.
Blitstein-Willinger E; Streller A
Clin Exp Immunol; 1987 May; 68(2):357-65. PubMed ID: 3115645
[TBL] [Abstract][Full Text] [Related]
22. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
Danis VA; Kulesz AJ; Nelson DS; Brooks PM
Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
[TBL] [Abstract][Full Text] [Related]
23. The interplay of interleukin-10 (IL-10) and interleukin-2 (IL-2) in humoral immune responses: IL-10 synergizes with IL-2 to enhance responses of human B lymphocytes in a mechanism which is different from upregulation of CD25 expression.
Itoh K; Inoue T; Ito K; Hirohata S
Cell Immunol; 1994 Sep; 157(2):478-88. PubMed ID: 8069928
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of pokeweed mitogen-induced immunoglobulin production in humans by gold compounds.
Rosenberg SA; Lipsky PE
J Rheumatol Suppl; 1979; 5():107-11. PubMed ID: 114639
[TBL] [Abstract][Full Text] [Related]
25. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug.
Hirohata S; Lipsky PE
Clin Immunol Immunopathol; 1993 Jan; 66(1):43-51. PubMed ID: 8440072
[TBL] [Abstract][Full Text] [Related]
26. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
[TBL] [Abstract][Full Text] [Related]
27. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice.
Tanaka K; Yamamoto T; Aikawa Y; Kizawa K; Muramoto K; Matsuno H; Muraguchi A
Rheumatology (Oxford); 2003 Nov; 42(11):1365-71. PubMed ID: 12810927
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of neovascularization in vivo by gold compounds.
Saura R; Matsubara T; Mizuno K
Rheumatol Int; 1994; 14(1):1-7. PubMed ID: 7939134
[TBL] [Abstract][Full Text] [Related]
30. The role of IL-10 in human B cell activation, proliferation, and differentiation.
Itoh K; Hirohata S
J Immunol; 1995 May; 154(9):4341-50. PubMed ID: 7722292
[TBL] [Abstract][Full Text] [Related]
31. Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors.
Saiki O; Ralph P
J Immunol; 1981 Sep; 127(3):1044-7. PubMed ID: 6973576
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
33. Effects of a gold salt on lymphocyte responses.
Harth M; Stiller CR; St C Sinclair NR; Evans J; McGirr D; Zuberi R
Clin Exp Immunol; 1977 Feb; 27(2):357-64. PubMed ID: 403043
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human B cell activation by a novel nonsteroidal anti-inflammatory drug, indometacin famesil.
Hirohata S; Yanagida T; Kawai M; Kikuchi H
Immunopharmacology; 1999 Nov; 44(3):245-54. PubMed ID: 10598881
[TBL] [Abstract][Full Text] [Related]
35. The gold anti-rheumatic drug auranofin governs T cell activation by enhancing oxygen free radical production.
Vint IA; Foreman JC; Chain BM
Eur J Immunol; 1994 Sep; 24(9):1961-5. PubMed ID: 8088316
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction.
Hirohata S; Yanagida T; Tomita T; Yoshikawa H; Ochi T
J Leukoc Biol; 2002 Jun; 71(6):987-95. PubMed ID: 12050184
[TBL] [Abstract][Full Text] [Related]
37. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
[TBL] [Abstract][Full Text] [Related]
38. Suppressed IL-2 production and response in AA rats: role of suppressor cells and the effect of auranofin treatment.
Lee JC; Rebar L; Demuth S; Hanna N
J Rheumatol; 1985 Oct; 12(5):885-91. PubMed ID: 2935633
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of in vitro proliferative response of cultured T lymphocytes to interleukin-2 by gold sodium thiomalate.
Wolf RE; Hall VC
Arthritis Rheum; 1988 Feb; 31(2):176-81. PubMed ID: 3126745
[TBL] [Abstract][Full Text] [Related]
40. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
Griswold DE; Lee JC; Poste G; Hanna N
J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
